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Abstract
Background: The evidence on diagnostic test accuracy (DTA) of diabetic retinopathy (DR) screening utilising
photographic studies by non-ophthalmologist personnel in low and middle-income country (LMIC) settings is
scarce. We aimed to assess DTA of DR screening using a nonmydriatic hand-held digital camera by trained general
physicians in a non-ophthalmic setting.
Methods: This study is a validation of a screening intervention. We selected 700 people with diabetes (PwDM) > 18 years
of age, not previously screened or treated for DR, presenting at a tertiary medical clinic in Sri Lanka. Two-field retinal
imaging was used to capture fundus images before and after pupil dilatation, using a hand-held non-mydriatic (Visuscout
100®-Germany) digital retinal camera. The images were captured and graded by two trained, masked independent
physician graders. The DTA of different levels of DR was assessed comparing physician’s grading with a retinologist’s
clinical examination by mydriatic bio-microscopy, according to a locally adopted guideline.
Results: Seven hundred eligible PwDM were screened by physician graders. The mean age of participants was 60.8 years
(SD ±10.08) and mean duration of DM was 9.9 years (SD ±8.09). Ungradable image proportion in non-mydriatic imaging
was 43.4% (either eye-31.3%, both eyes 12.1%). This decreased to 12.8% (either eye-11.6%, both eyes-1.2%) following pupil
dilatation. In comparison to detection of any level of DR, a referable level DR (moderate non-proliferative DR and levels
above) showed a higher level of DTA. The sensitivity of the defined referable DR was 88.7% (95% CI 81.7–93.8%) for
grader 1 (positive predictive value [PPV] 59.1%) and 92.5% (95% CI 86.4–96.5%) for grader 2 (PPV 68%), using mydriatic
imaging, after including ungradable images as screen positives. The specificity was 94.9% (95% CI 93.6–96.0%) for grader 1
(negative predictive value [NPV] 99%) and 96.4% (95% CI 95.3–97.3%) for grader 2 (NPV 99.4%).
Conclusions: The Physicians grading of images from a digital hand-held non-mydriatic camera at a medical clinic, with
dilatation of pupil of those who have ungradable images, provides a valid modality to identify referable level of DR. This
could be a feasible alternative modality to the existing opportunistic screening to improve the access and coverage.
Trial registration: Current Controlled Trials ISRCTN47559703. Date of Registration 18th March 2019,
Retrospectively registered.
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Background
Diabetic retinopathy (DR) is a common complication of
diabetes mellitus (DM), leading to sight loss if not de-
tected and treated in time [1]. The International Dia-
betes Federation (IDF) estimated that cases of DM will
increase to 629 million by 2045, with a significant bur-
den (80%) in low and middle income countries (LMIC)
[2]. Systematic DR screening (DRS) is a challenge in
many of the LMICs due to limited resources [3]. The St
Vincent declaration stated that all nations should make
efforts to reduce DM related complications, including
DR blindness [4]. These recommendations were followed
by most of the high-income countries (HICs). The
LMICs would also be able to achieve this aim with the
adaptation and use of existing technologies according to
the local contextual requirements.
The most common method of detecting DR in LMICs
is direct ophthalmoscopy and slit-lamp bio-microscopy.
The direct ophthalmoscopy has a low sensitivity and
specificity even at the hands of experienced eye care spe-
cialists [5]. The mydriatic bio-microscopic examination
by an ophthalmologist is not practical in these countries
due to the low number of ophthalmologists and eye
clinics which are already over-subscribed with more
common blinding conditions such as cataract [6]. In
these circumstances, DR is detected through opportunis-
tic case detection only. Insufficient capacity and lack of
screening infrastructure hampers efforts to implement
DRS programs (DRSP) in these settings, and there is a
lack of evidence of what works in LMICs [7–9].
Different models of DRS have been implemented in
many parts of the world. In resource poor LMICs devel-
opment of a DRS model is complex [10]. The lack of
trained human resources and infrastructure has out-
stripped the capacity to deliver systematic DRS in low
income settings [11]. There are also poor recording sys-
tems to identify the people with DM (PwDM). There-
fore, a comprehensive population-based DRSP may not
be feasible in LMICs in the near future [8, 10]. DRS also
requires appropriate integration into routine care for
sustainability [10]. It was shown that public health inte-
gration of DRS is a feasible strategy to control avoidable
blindness [12]. As such, one feasible model of systematic
DRS in LMICs could be screening of PwDM when they
attend for routine medical care. This can provide a par-
ticipant list of PwDM, who can be offered screening at
regular intervals. Integrated DRS at medical care clinics
can also facilitate risk stratification and prioritisation of
referrals to busy eye clinics. In these circumstances, a
key consideration would be the availability of skilled hu-
man resources facilitating task shifting and sharing and
efficient, cost effective and valid technology for DRS.
Retinal fundus photography is the most common DRS
method used globally [13] and digital systems are mostly
preferred [14]. Conventional desk-top digital cameras re-
quire significant physical space, skilled photographers
and large image storage devices which incur high capital
investment but are cost effective [15]. Hand-held digital
cameras are portable, require less space, minimum
power consumption and less skills and training [16].
Non-mydriatic retinal imaging is more popular consider-
ing the convenience for both service user and provider
due to absence of procedures such as pupil dilatation
[17]. However, this may have an impact on image grad-
ability and screening coverage [18].
Hand held retinal cameras use for DRS in various set-
tings and outcomes mainly depend on the image quality.
Yogesan et al., (2000) reported that images captured by a
hand-held camera were not suitable for tele-screening
due to poor quality (only 24% in good quality). However
in this study sample size was very low (n = 25 partici-
pants, 49 eyes) [19]. A study conducted in France, con-
cluded that hand-held retinal imaging system was less
efficient with poor image quality. However, in this study
the photographer had undergone training only on 10 pa-
tients before the study, which is a highly inadequate for
a hand-held camera [20]. In contrast, A study conducted
in China reported that 63% of the images were in excel-
lent quality, however the age of the participants was
started as low as 9 years (age range 9–84 years) [21]. A
review by Cuadros et al., (2017) concluded that
hand-held cameras are practically convenient but do not
provide sufficient image quality [22]. Therefore, quality
of the images is a major concern in hand-held devices,
though they are easy to use.
To the authors’ knowledge there is no evidence on
DRS using digital retinal imaging from Sri Lanka. A situ-
ational analysis conducted in the Western province
showed a large gap in DRS services delivery compared
to the estimated need [23]. This study aims to demon-
strate the functional and technical feasibility of using a
hand-held non-mydriatic digital camera in a LMIC
non-ophthalmic setting. We assessed the DTA of DR de-
tection by general physicians using this method com-
pared to the local clinical reference standard of
mydriatic indirect ophthalmoscopy and bio-microscopic
examination by a retinologist.
Methods
Ethics approval was obtained from both ethics review
committees of the London School of Hygiene & Tropical
Medicine-United Kingdom and the National Eye
Hospital-Sri Lanka. This study adhered to the tenets of
the ‘Declaration of Helsinki’ and written informed con-
sent was obtained from all participants. A prospective
screening intervention validation study was conducted
between May 2017 and May 2018 at a tertiary level, pub-
lic sector out-patient medical clinic in the Western
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province of Sri Lanka. The main outcome measure was
detection of signs of DR (any DR or a referable level) by
physician graders using captured digital images, accord-
ing to a locally adopted guideline. The protocol of this
validation study has been published in Journal of Med-
ical Internet Research (JMIR-doi:https://doi.org/10.2196/
10900) and a summary is outlined below [24].
Summary of the methods
Nine general physicians from a tertiary level institution
underwent a competency-based training programme fol-
lowing written informed consent, delivered by two retinolo-
gists. The training included the following: capturing retinal
fields using a hand-held non-mydriatic fundus camera
(Zeiss-Visuscout100®-Germany), identification of signs of
DR using images and DR grading according to an adopted
classification system based on the United Kingdom - Na-
tional Screening System [25] (Additional file 1: Table S1).
The hand-held imaging system has the ability to capture
colour and red free retinal images in a range of + 20 diop-
ters (D) to − 20 D, at 40 0 field of view angle. The camera
comprised of 9 fixation targets and resolution of the camera
is 800 × 480 (5 megapixels). Guidelines were used to
standardize reporting of image quality, and ungradable im-
ages were classified based on the proportion of the retina
visible for grading (Additional file 1: Figure S1). Physicians
were tested using a set of standard images of DR and the
two who reached the required level of agreement with the
retinologist (k = 0.8–0.9) were selected as graders in the val-
idation study.
A sample size of n = 506 participants was chosen, in
order to estimate the sensitivity within a margin of error
10% (based on 95% confidence intervals), with an ex-
pected sensitivity of 70% and prevalence of moderate
NPDR among PwDM of 20%. This included an additional
25% to take account of ungradable images (i.e., < 50% of
the retina visible). Interim analysis was undertaken to as-
certain the level of ungradable images and, to take account
of a higher than expected proportion of ungradable im-
ages, the sample size was increased to 700 PwDM. A con-
secutive sample (n = 700) of diagnosed PwDM (> 18 years)
without previous DRS at an eye clinic who were included
in the study following written informed consent. Partici-
pants were identified at a tertiary level medical clinic, in
the Western province of Sri Lanka.
In the index test imaging, two-field (1st field-macula can-
tered, 2nd field-disc centred) (Additional file 1: Figure S2),
45-degree retinal images were captured in each eye before
and after pupillary dilatation, using 2% phenylephrine, fol-
lowing adequate mydriasis (5–6mm) by each physician
grader. During grading, the non-mydriatic images were
graded first. We calculated DTA at 3 levels for the
non-ophthalmic settings: i.e., 1) any DR (detection of R1,
R2, R3 and R4), 2) referable DR (R2 and above) and 3)
detection of referable level and maculopathy combined with
a visual acuity cut off (worse eye > 6/18 Snellen visual acuity)
(see Additional file 1: Table S1). The graders were masked
to the history and clinical examination findings and pupil
status of the images. The clinical reference test entailed a de-
tailed, dilated fundus examination by an experienced trainer
retinologist using slit-lamp bio-microscopy with a 90D lens
and indirect ophthalmoscopy using a 20D lens. The refer-
ence test was conducted by one retinologist with more than
15 years of clinical experience in vitreo-retina field. The
7-field ‘Early Treatment diabetic Retinopathy Study’ refer-
ences test was logistically not feasible in this resource poor
setting. This reference examination took place as soon after
imaging as possible in all 700 PwDM that were included in
the index test. The retinologist was masked to the clinical
status and physician graders’ findings.
For quality assurance, 15% of each non-mydriatic and
mydriatic image sets were evaluated by the retinologist for
technique, ability to image the required field and gradabil-
ity. Fifteen percent of each hundred image sets were given
back to the physician graders for double grading to assess
the repeatability and intra-grader agreement in the 1st
and 2nd attempts of grading images. A sample of the same
image sets (n = 212) were graded by the retinologist to cal-
culate inter-grader agreement.
Analysis
Data were entered in to an MS Excel-16.0 worksheet
and transferred to SPSS-Version-20.0 (Armonk-NY-IBM
Corp-2011) and STATA/IC-Version-14.2 (Texas-77,
845-USA) for analysis. DTA variables of sensitivity, spe-
cificity and predictive values and agreement analyses
(kappa statistics) were calculated with 95% confidence
intervals, for each grader and each pupil status com-
pared to the reference standard using individual eyes as
the unit of analysis, considering each gradable eye as a
separate case. Two approaches were used in the calcula-
tions to examine the impact of ungradable images on
the outcomes. i.e., by excluding the ungradable images
and by including ungradable as test positive in the ana-
lysis. As ungradable images indicate a requirement for
referral to an eye clinic, we analysed ungradable images
as screen positives to examine the sensitivity and specifi-
city of detecting a need for referral. This also allows
comparisons with previous studies, which have used
both methods.
Subgroup analysis conducted for identification of pres-
ence/absence of DR (any DR), moderate NPDR and
above with / without macular signs, to make recommen-
dations for a referable criterion for the local context. We
used different referable criteria i.e., by pupil status, level
of DR, level of visual acuity and presence of macular
signs in the analysis to understand the variation in DTA
to assess the most suitable and accurate cut off level of
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DR without overloading the eye clinic and also facilitat-
ing safe practice at a non-ophthalmic setting.
Results
Participants’ characteristics
Of the 826 eligible PwDM identified from medical clin-
ical records, response rate was 84.7% (700/826). Mean
age of the participants was 60.8 years (SD ±10.08) and
majority were women (66%, 462/700). Only 27.9% (195/
700) of the participants were employed and 79.1% (554/
700) lived in the capital city of Colombo and hailed from
low income families (88%, 616/700, monthly income <
£150). Of these, 98.4% (689/700) had type 2 DM and
1.6% (11/689) were diagnosed with DM at age < 30 years
and were on insulin. The mean age at diagnosis of DM
was 50.9 years (SD ±11.03) and mean duration of diabetes
was 9.9 years (SD ±8.09). Mean fasting plasma glucose with
in the last 3months was 140.4mg/dl (SD ±55.43).
Additional co-morbidities included; hypertension (70%),
hyperlipidaemia (57.3%), ischaemic heart disease (31.9%),
nephropathy (9%) and neuropathy (35%). The Table 1
shows the characteristics of the PwDM in this study. The
maximum time interval between index and reference test
was 4 weeks.
Image gradability and number of images sets available
for DTA analysis
Seven hundred PwDM were included in the study and
126 (15.2%, 126/826) were excluded (n = 69-no consent
and n = 57-did not attend for imaging) (See Fig. 1). Since
both physician graders captured image sets of each par-
ticipant, ideally there should be 1400 image sets (by
eyes) for each grader for each pupil status. However, we
ended up as shown in Additional file 2 - flow chart, due
to technical errors in storage and failure to track PwDM
(8–20 eyes, 0.6–1.4%) at the medical clinic. Overall
ungradable proportion in non-mydriatic imaging was
31.0% (217/700) for at least one eye ungradable for ei-
ther grader. In 12.0% (84/700) both eyes were ungrad-
able for both graders. This decreased to 11.4% (80/700)
and 1.1% (8/700) respectively, following pupil dilatation.
We noted that 9 PwDM (18 eyes) did not attend for the
reference test. In addition, reference test was not pos-
sible in 40 eyes (40/1400, 2.8%, in 21 participants: 37 ad-
vanced lens opacity, 1 posterior capsular opacity, 1
phthisical eye 1 and 1 eviscerated). After excluding eyes
of those who did not attend and ungradable even at the
reference test (total n = 58) we left with 1342 image sets
(by eyes) in DTA analysis. Overall there were 1041 DR
positive eyes and 301 DR negative eyes as identified at
the reference test. The technical failure rates by the area
of visibility of the retinal fields for each image set in the
index test by pupil status and grader level (by eyes) are
described in the Table 2 and Additional files 2 and 3. In
addition, a very good gradability agreement (range k =
0.72–0.96) was observed for physician graders in com-
parison to retinologist’s findings using a sample of
images.
DTA after including ungradable images (primary analysis)
We aimed to demonstrate the DTA for referrals to eye
clinic rather than the DTA of detecting DR in the pri-
mary analysis. When considering the ungradable images
as screen positives, sensitivity of detection of any level of
DR using non-mydriatic imaging was 82.7% (95% CI
78.4–86.5%) in grader 1 and 78.3% (95% CI 73.7–82.5%)
in grader 2. However, since they were referring a higher
proportion of ungradable, probably those who did not
have the disease, specificity values dropped to 70.4%
(95% CI 67.6–73.1%) in grader 1 and 76.2% (95% CI
73.6–78.7%) in grader 2 in non-mydriatic imaging. In
mydriatic imaging when we included the ungradable im-
ages in the analysis sensitivity was 79.3% (74.7–84.8%) in
grader 1 and 78.0% (95% CI 73.4–82.2%) in grader 2.
The specificity value of grader 1 was 89.2% (95% CI
87.2–90.9%) and grader 2 was 91.5% (95% CI 89.7–
93.1%). The sensitivity, specificity, NPV, PPV and kappa
agreement at different levels of DR after including the
ungradable images are described in Table 3.
DTA after excluding ungradable images
The DTA estimates were calculated after excluding
ungradable images (< 50% of the field visible) in the next
step as an accuracy measure of the modality. In the
comparison physician’s grading using 2-field imaging
against the clinical reference standard, in detection of
any level of DR, there was no significant difference in
DTA by pupil status, in each grader. Similar results were
observed in detection of macular signs. Table 4 shows
the sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) for each grader and
for each pupil status for this analysis. A higher range of
PPV values were observed in detecting a referable level
DR (79.7–92.8%) (moderate non-proliferative DR and
above) compared to identification of macular signs
(63.2–73.5%) (presence of haemorrhage/s or exudate/s
within 2-disc diameters of centre of fovea). However,
such differences were not observed in NPV.
Sub-analyses of DTA
As a pragmatic approach for a resource poor non-oph-
thalmic setting, we reported the DTA of DRS using
non-mydriatic imaging and dilatation of the pupils of only
those who have ungradable images (two-step process). In
this sub-analysis, the eye which was ungradable even fol-
lowing mydriasis were considered as screen positives. We
derived a sensitivity of referable level of DR 81.1% (95% CI
72.9–87.9%) for grader 1 and 82.1% (95% CI 74.0–88.6%)
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for grader 2. The specificity values were 95.4% (95% CI
94.2–96.5%) for grader 1 and 97.1% (95% CI 96.1–97.9%)
for grader 2 in this approach. We observed an improved
level of PPV (59.7–70.2%) and NPV (98.4–98.5%) in this
strategy. The details are described in Additional file 4.
We combined the DTA of the detection of referable
level DR (moderate NPDR and above) with positive
macular signs, using non-mydriatic imaging, where the
sensitivity was 79.0% for grader 1 and 70.8% for the
grader 2. These estimates improved to 84.5 and 85.8%
respectively for grader 1 and 2 after dilatation. For the
same referable level specificity values were 96.6 and
98.0% for grader 1 and 2 respectively and there was no
significant change with the pupil dilatation (non-mydria-
tic grader 1–97.3%, grader 2–98.4%).
We also incorporated visual acuity threshold for referrals
(considering worse eye visual acuity 6/18 and above, retinop-
athy moderate and above and positive macular signs) and
found a sensitivity of grader 1 was 98.3% (95% CI 94.9–
99.7%) and grader 2, 97.4% (95% CI 93.5–99.3%). However,
in the same referable level specificity values showed an over-
all reduction (grader-1 49.4, 95% CI 45.3–53.5% and grader-2
51.6, 95% CI 47.5–55.7%), probably due to high number of
PwDM referred to the next level without ≥ moderate NPDR.
These approaches will be useful in making recommendations
for a referable level for a non-ophthalmic setting.
Table 1 Participants’ characteristics
Variable Categories Results
Mean age Mean 60.8 years (SD 10.1)
Sex Male 34% (n = 238)
Female 66% (n = 462)
Employment status Employed 27.9%(n = 195)
Unemployed 41.0% (n = 287)
Retired 31.1%(n = 218)
Monthly household income Low (<£150) 88.0% (n = 616)
Middle (>£150 - < £300) 9.6% (n = 67)
High (>£300) 2.4% (n = 17)
Ethnic group Sinhalese 66.9% (n = 468)
Tamil 16.4% (n = 115)
Moor 14.1%(n = 99)
Other 2.6% (n = 18)
Age at diagnosis of diabetes Mean 50.9 years (SD 11.0)
Duration of diabetes Mean 9.9 years (SD 8.1)
Current treatment of DM Diet only 5.6% (n = 39)
Oral medication only 79.7% (n = 558)
Insulin only 5.6% (n = 39)
Oral medication and insulin 9.1% (n = 64)
Fasting glucose level (within 3 months) Mean 140.44 mg/dl (SD 55.4) 95% CI (136.2–144.0)
HbA1c level (only n = 42 available) Mean 7.9% (SD 2.2) 95% CI (7.3–8.7)
Other comorbidities Hypertension 70%
Hypercholesterolaemia 57.3%
Ischaemic heart disease 31.9%
Nephropathy 9%
Neuropathy 35%
Leg / peripheral ulcers 5%
Age at diagnosis of hypertension Mean 52.8 years (SD 9.6)
Family history Diabetes 63.3%
Hypertension 50.4%
Hypercholesterolaemia 30%
Ischaemic heart diseases 28.7%
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Fig. 1 Flow chart of the number of participants and image sets used in the DTA analysis
Table 2 Gradability of the images as marked by each grader and agreement with the reference grader
Gradability percentage of
the retinal fields
Non-mydriatic imaging Mydriatic imaging
Grader 1
Nc = 1392
Grader 2
N = 1391
Grader 1
N = 1381
Grader 2
N = 1380
Gradable
100% a 286 (20.5%) 352 (25.3%) 537 (38.9%) 605 (43.8%)
75% 308 (22.1%) 431 (31.0%) 395 (28.6%) 519 (37.6%)
50% 386 (27.7%) 276 (19.8%) 351 (25.4%) 186 (13.5%)
Ungradable
<50% 412 (29.6%) 332 (23.9%) 98 (7.1%) 70 (5.1%)
Inter-grader Agreement b, kappa (95% CI) 0.90 (0.85,0.95) 0.90 (0.86,0.95) 0.72 (0.56,0.89) 0.96 (0.89,1.03)
a. Percentage of visibility in a given field, by eyes
b. Physician grader vs retinologist – grading a random sample of image sets (n = 212, total n = 424)
c. Number of image sets by eyes
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Agreement analysis
The percentage of image gradability agreement, between
index graders and retinologist (inter-grader agreement), in
non-mydriatic imaging; grader 1 was 85.2% ([kappa] k = 0.9,
95% CI 0.85–0.95) and grader 2, 78.5% (k = 0.9, 95% CI
0.86–0.95). In mydriatic imaging, inter-grader gradability
agreement of grader 1 was 76.2% (k = 0.72, 95% CI 0.56–
0.89) and grader 2, 72.7% (k = 0.96, 95% CI 0.89–1.03).
We proposed grading the same images by the retinolo-
gist would provide a fair comparison for the physician
graders in agreement analysis. However, here the con-
cerns were limitations in the degree of view of a
hand-held retinal camera and skills of capturing images
by the physicians. In this analysis, in the grading of DR
and macular signs, we found that inter-grader agreement
was mostly > 0.8 except for the grader 2 non-mydriatic
images (any DR k = 0.80–0.89, referable DR k = 0.77–
0.85, macular signs k = 0.77–0.85). We observed a satis-
factory level of agreement of the physician graders find-
ings using a 2-field modality. The overall concordance of
the results is described in Table 5.
Quality assurance
The index graders re-graded the coded image sets in a
masked fashion independently without having access to
the first attempt data. In this, first attempt vs second at-
tempt weighted kappa agreement was calculated to as-
sess the repeatability of DR grading at level of
retinopathy. The kappa value of grader 1 was 0.69 (95%
CI 0.60–0.78) and grader 2, 0.66 (95% CI 0.58–0.73). In
comparison of grader 1 vs grader 2, first attempt kappa
was 0.82 (95% CI 0.76–0.89) and in second attempt it
was 0.74 (95% CI 0.66–0.83%) (see Additional file 5).
Reasons for ungradability of images, prevalence of DR
and time and flow of the participants
We described the possible reasons for ungradability,
using the highest recorded ungradability values, which
was observed by grader 1. Of the 29.4% of ungradable
images for grader 1, non-mydriatic imaging, 69.2% (285/
412) had lens opacity. Among these 29.8% (85/285) eyes
had significant level of lens opacity which required cata-
ract assessment. Following reference test 37 eyes were
identified as having lens opacities that required urgent
cataract surgery. Overall, 75.6% of the participants had
no DR, 16.7% mild DR (R1), 3.6% moderate NPDR (R2),
0.4% severe NPDR (R3) and only 1% had PDR (R4).
Among the ungradable images in non-mydriatic imaging,
66.5% (274/412) had no retinopathy (R0), 19.9%-mild
NPDR (R1), 1.7%-moderate NPDR (R2), 0.7%-severe
Table 3 Diagnostic test accuracy of each grader by each pupil status (unit of analysis, by eyes, after including ungradable images)
Index Test Sensitivity (95% CI) (%) Specificity (95% CI) (%) PPV (95% CI) (%) NPV (95% CI) (%) Kappa (95% CI) (%)
Any DR grading
Non-mydiatric image
Grader 1 82.7 (78.5, 86.5) 70.4 (67.6, 73.1) 47.4 (43.4, 51.5) 92.7 (90.7, 94.4) 0.42 (0.38, 0.47)
Grader 2 78.3 (73.7, 82.5) 76.2 (73.6, 78.8) 51.6 (47.3, 55.9) 91.6 (89.6, 93.3) 0.46 (0.42, 0.51)
Mydiatric image
Grader 1 79.3 (74.7, 83.4) 89.2 (87.2, 90.9) 70.3 (65.6, 74.8) 93.0 (91.3, 94.5) 0.66 (0.61, 0.70)
Grader 2 78.0 (73.4, 82.2) 91.5 (89.7, 93.1) 74.7 (70.0, 79.1) 92.8 (91.1, 94.3) 0.68 (0.64, 0.73)
Referable DR grading a
Non-mydiatric image
Grader 1 86.8 (79.5, 92.3) 71.7 (69.2, 74.2) 20.4 (16.9, 24.3) 98.5 (97.6, 99.1) 0.23 (0.19, 0.28)
Grader 2 84.9 (77.3, 90.9) 77.3 (75.0, 79.6) 23.8 (19.7, 28.3) 98.4 (97.5, 99.0) 0.29 (0.23, 0.34)
Mydiatric image
Grader 1 88.7 (81.7, 93.8) 94.9 (93.6, 96.0) 59.1 (51.4, 66.6) 99.0 (98.4, 99.5) 0.68 (0.61, 0.75)
Grader 2 92.5 (86.4, 96.5) 96.4 (95.3, 97.3) 68.0 (60.2, 75.3) 99.4 (98.8, 99.7) 0.76 (0.70, 0.82)
Maculopathy grading b
Non-mydiatric image
Grader 1 89.2 (83.5, 93.5) 70.1 (67.5, 72.6) 26.5 (22.7, 30.4) 98.2 (97.2, 98.9) 0.29 (0.25, 0.34)
Grader 2 80.4 (73.5, 86.6) 77.0 (74.6, 79.3) 29.7 (25.3, 34.3) 97.0 (95.8, 98.0) 0.33 (0.28,0.38)
Mydiatric image
Grader 1 86.5 (80.4, 91.4) 91.5 (89.8, 92.9) 54.9 (48.5, 61.2) 98.3 (97.4, 98.9) 0.62 (0.56,0.68)
Grader 2 82.4 (75.8, 87.9) 95.4 (94.1, 96.5) 68.2 (61.1, 74.7) 97.0 (96.9, 98.6) 0.71 (0.65,0.77)
a-Referable level DR – moderate non-proliferative DR and above
b-Maculopathy – presence of haemorrhage/s or exudates within 2-disc diameters of the centre of fovea
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NPDR (R3) and 1.5%-proliferative DR (PDR-R4) (see
Additional file 3).
The mean time gap between index imaging and reference
test was 3.6 days (SD ± 0.2) (95% CI 3.2–4.0, range 0–48
days). Six hundred and ninety-two PwDM completed the
reference test examination and 98% (684/692) of them
underwent retinologists examination < 4 weeks period.
Discussion
We demonstrated that DRS by general physicians using a
mydriatic two field technique was a feasible modality to de-
tect a defined level of referable DR (moderate NPDR and
above, after including ungradable images: sensitivity 88.7–
92.5% and specificity 94.9–96.4%) in a non-ophthalmic set-
ting, considering the level of DTA achieved. This may be
suitable for LMIC settings where it would be difficult to im-
plement full population based DRSP due to resource and
information constraints. Compared to a locally accepted
clinical reference standard, DRS using mydriatic 2-field
strategy by general physicians showed an accepted level of
DTA which most of the HIC screening programs follow
(sensitivity of > 80% and specificity of > 95%) [25]. We as-
sumed that inclusion of ungradable images in the DTA ana-
lysis is a pragmatic approach for a non-ophthalmic setting,
considering the requirement of referring those PwDM to
the eye clinic for further assessment and treatment. The
proposed imaging strategy could act as a filter minimizing
the number of referrals at eye clinic, thereby reducing the
strain on the system. The United Kingdom prospective dia-
betes study group (UKPDS) reported that 15.3% of those
with signs of DR at baseline, required laser at 3 years [26].
Therefore, identification of even minor levels of DR will be
beneficial to stratify the risk groups early.
Digital retinal imaging showed promising results in
DRS [25]. The digital imaging systems have the advan-
tage of instant availability of images for quality assess-
ment and convenient storage and retrieval. Several
studies have compared digital fundus photography with
7-fields used in early treatment diabetic retinopathy
study (ETDRS) [27–29] or mydriatic ophthalmoscopy
[30, 31] in DRS and shown an acceptable level of DTA.
The DTA studies from high income countries (HIC)
used trained graders or ophthalmologists/retinologists in
index test and table top static cameras with advanced
technology such as wider angle and high resolution,
which may be prohibitively expensive for LMICs.
Though DTA is lower in this study, this strategy would
be useful in a context where there is no systematic DRS.
On the other hand, it may be arbitrary to compare the
findings of this study with HICs. LMICs such as Sri
Table 4 Diagnostic test accuracy of each grader by each pupil status (unit of analysis, by eyes, after excluding ungradable images)
Index Test Sensitivity (95% CI) (%) Specificity (95% CI) (%) PPV (95% CI) (%) NPV (95% CI) (%) Kappa (95% CI) (%)
Any DR grading
Non-mydiatric image
Grader 1 71.1 (64.9, 77.4) 95.6 (94.1, 97.0) 80.8 (75.0, 86.6) 92.7 (90.8, 94.5) 0.70 (0.64, 0.76)
Grader 2 66.4 (60.0, 72.7) 95.4 (94.0, 96.8) 78.9 (72.9, 84.9) 91.7 (89.8,93.5) 0.66 (0.60,0.72)
Mydiatric image
Grader 1 76.2 (71.3, 81.0) 94.0 (92.6, 95.5) 79.1 (74.4, 83.9) 93.0 (91.4, 94.6) 0.71 (0.66, 0.76)
Grader 2 75.2 (70.2, 80.1) 93.9 (92.5, 95.4) 78.3 (73.6, 83.1) 92.9 (91.3, 94.5) 0.70 (0.65, 0.75)
Referable DR gradinga
Non-mydiatric image
Grader 1 73.6 (61.7, 85.5) 99.7 (99.3, 100.0) 92.9 (85.1, 100.7) 98.5 (97.7, 99.3) 0.81 (0.72, 0.90)
Grader 2 71.7 (59.6, 83.8) 99.0 (98.4, 99.6) 79.2 (67.7, 90.7) 98.5 (97.8, 99.3) 0.74 (0.64, 0.84)
Mydiatric image
Grader 1 81.8 (72.5, 91.1) 99.4 (99.0, 99.9) 88.5 (80.5, 96.5) 99.0 (98.5, 99.6) 0.84 (0.77, 0.91)
Grader 2 89.4 (82.0, 96.8) 98.8 (98.2, 99.4) 79.7 (70.6, 88.9) 99.4 (99.0, 99.9) 0.83 (0.77, 0.90)
Maculopathy gradingb
Non-mydiatric image
Grader 1 78.1 (68.6, 87.6) 96.6 (95.5,97.8) 65.5 (55.5, 75.5) 98.1 (97.29, 99.1) 0.69 (0.60, 0.77)
Grader 2 64.1 (53.5, 74.8) 98.1 (97.3, 99.0) 73.5 (63.0, 84.0) 97.1 (96.1, 98.2) 0.66 (0.57, 0.75)
Mydiatric image
Grader 1 81.0 (73.3, 88.7) 96.0 (94.9, 97.1) 63.3 (54.9, 71.6) 98.3 (97.6, 99.1) 0.68 (0.61, 0.75)
Grader 2 75.3 (66.8,83.7) 97.8 (96.91, 98.6) 73.8 (65.3,82.3) 97.9 (97.1, 98.7) 0.72 (0.65, 0.79)
a-Referable level DR – moderate non-proliferative DR and above
b-Maculopathy – presence of haemorrhage/s or exudates within 2 disc diameters of the centre of fovea
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Lanka require pragmatic solutions for control of visual
loss due to DR with rising prevalence of DM.
The optimum number of retinal fields in a DRS strat-
egy is a key factor that affects accuracy. The ETDRS
7-field strategy is considered to be the gold standard for
DR detection but is not practical in a screening program
[32]. Previous studies showed that single retinal field is
inadequate to achieve required standards [33–37]. Stud-
ies have also demonstrated that 3-fields would not im-
prove DTA of detection of any referable DR [38]. A
non-mydriatic two field strategy in detection of sight
threatening DR (STDR) in a HIC showed a sensitivity of
92% (95% CI 90–94%) and specificity of 96% (95% CI
95–98%) (proportion of ungradability - non-mydriatic
15.3–17.6%, mydriatic 1.4–2.1%) [27]. In our study, sen-
sitivity was 71.7–73.5% and specificity 98.9–99.6% for
detection of referable DR using non-mydriatic imaging.
We could not achieve a higher level of sensitivity com-
parable with the studies done in HICs, due to poor
image quality. The main causes of poor image quality
are dark iris colour, poor pupil dilation status and lens
opacity [17, 39]. In HICs prevalence of cataract is less
compared to LMICs like Sri Lanka [40–42]. We ob-
served that sensitivity increased to 81.8–89.3% when
pupils were dilated. In addition, specificity was high irre-
spective of the pupil status, because physician graders
were confident in grading in the absence of any signs.
The study by Henricsson, M. et al. (2000) showed that
dilatation and increasing number of fields to 5, the DTA
improved to sensitivity of 93% and specificity of 91%
[43]. It is apparent that one or more fields to the two
central fields in DRS, has increased DTA minimally [28].
Therefore, a 2-field DRS strategy is justifiable for this
context. In addition, slit-lamp examination by the reti-
nologist is a justifiable reference test for this context.
Scanlon, PH. et al., (2003) showed that there was no sig-
nificant difference in the assessment of DTA between
using 7-field ETDRS and slit lamp examination by oph-
thalmologists [31].
In some settings, several non-ophthalmological personnel
had been employed in DRS. In our study we proposed DRS
by trained general physician at medical clinic following as-
sessment of barriers. The estimates from previous studies
are comparable with the finding of our study [39]. In a study
from the United Kingdom, DRS by general practitioners
using 35mm colour images shown that detecting any level
of DR was increased from 62.6% (95% CI 55.9–69.4%) with
direct ophthalmoscopy to 79.2% (95% CI 73.6–84.9%) using
Table 5 Agreement by comparing findings of sample of same images (captured by physicians) graded by retinologist (inter-grader
agreement: physician grader 1 or 2 vs retinologist) (n = 212, 424 image sets)
Index Test Sensitivity (95% CI) (%) Specificity (95% CI) (%) Kappa value (95% CI) (k)
Any DR grading
Non-mydriatic image
Grader 1 92.3 (86.4, 98.2) 96.8 (94.5, 99.1) 0.89 (0.83, 0.95)
Grader 2 84.9 (77.3, 92.5) 94.9 (92.1, 97.7) 0.80 (0.73, 0.88)
Mydriatic image
Grader 1 90.2 (85.0, 95.5) 96.7 (94.6, 98.8) 0.88 (0.82, 0.93)
Grader 2 90.5 (85.5, 95.6) 95.0 (92.5, 97.6) 0.85 (0.80, 0.91)
Referable DR grading a
Non-mydriatic image
Grader 1 80.0 (64.3, 95.7) 99.3 (98.3, 100.3) 0.84 (0.72, 0.96)
Grader 2 79.2 (62.3, 95.4) 98.3 (96.9, 99.8) 0.77 (0.64, 0.91)
Mydriatic image
Grader 1 77.1 (63.2, 91.1) 98.9 (97.8, 100.0) 0.80 (0.69, 0.91)
Grader 2 97.0 (91.1, 102.9) 97.6 (96.4, 99.2) 0.85 (0.76, 0.94)
Maculopathy grading b
Non-mydriatic image
Grader 1 94.3 (86.6, 102.0) 97.0 (94.9, 99.0) 0.85 (0.76, 0.94)
Grader 2 75.0 (61.6, 88.5) 98.2 (96.7, 99.8) 0.77 (0.66, 0.88)
Mydriatic image
Grader 1 88.1 (79.9, 96.4) 96.5 (94.5, 98.4) 0.82 (0.74, 0.90)
Grader 2 76.6 (66.2, 86.9) 98.5 (97.3, 99.8) 0.80 (0.72, 0.89)
a-Referable level DR – moderate non-proliferative DR and above
b-Maculopathy – presence of haemorrhage/s or exudates within 2-disc diameters of the centre of fovea
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retinal photographs (and specificity remained unchanged
(direct ophthalmoscopy 75.0% (95% CI 69.5–80.5%) vs
73.5% (95% CI 68.0–79.1%)) [44]. They concluded that ret-
inal photography by trained general practitioners in primary
care setting could achieve an acceptable level of detection of
STDR (87%) [44]. In our validation study physician graders
showed a sensitivity range of 88.6–92.4% and specificity
range of 94.8–96.3% in detection of referable level of DR
using mydriatic imaging which is better than the reported
studies. However, this may depend on the proportion of
ungradable images. In our sub-analysis we included the tech-
nical failures as test positives, since physician graders refer
these to the eye clinic. A review of 22 cross sectional photo-
graphic studies showed non-mydriatic retinal photography
sensitivity range of 25–66% for general practitioners, 43–79%
for optometrists and 27–73% for other non-ophthalmic
health professionals and an overall specificity of > 91% [45].
The sensitivity of detection of any level of DR increased to
87–100% for general practitioners and > 91% for optometrists
with pupil dilatation [45]. As a first line, this study has shown
that physician graders are capable of DRS in a non-ophthal-
mic setting in Sri Lanka. However, we will have to study the
effectiveness of this modality in a larger number to make
specific recommendations to implement a population-based
program.
In our study 75.6% of the participants had no DR,
16.7% mild DR (R1), 3.6% moderate NPDR (R2), 0.4%
severe NPDR (R3) and only 1% had PDR (R4). A study
conducted among the slum populations (age > 40 years,
known PwDM) in India, using a hand-held nonmydriatic
camera reported 8.1% severe NPDR and 6.8% PDR
which are higher prevalence than our study [46]. One
reason for higher prevalence could be poor diabetes
management among the slum populations. However, in
this study, relatively a higher gradability of images
(89.4% gradable) was observed even in non-mydriatic
mode, probably due to images were graded at the site
after directly visualising on the display of the hand-held
camera. We have noticed that image quality is appar-
ently higher on a small screen compared to displaying
on a traditional viewing monitor. In another study con-
ducted in India, among 500 PwDM at an endocrinology
clinic, proportion ungradable was 30.6 and 31% among
two observers which is comparable to our results [39].
In comparison we observed that studies conducted in
HICs reported high proportions of gradability compared
to our study. A study conducted in USA 86–94% images
were gradable before pupil dilatation in hand-held ret-
inal imaging [47]. Similarly a study conducted in a upper
middle income setting (China) reported a low ungrad-
able proportion of 4.75% (19/400) using a hand-held
camera [21]. The low prevalence of DR in our study
could be attributed to many factors. One reason for this
would be excluding those who had undergone previous
DRS and treatment. In Sri Lanka about 50% of the
PwDM in clinics had DRS [48]. Forty percent (572/1398)
of the PwDM had previous DRS or DR treatment in our
study. The high proportion poor image quality in our
study could be due to smaller pupil size and presence of
lens opacities.
Non-mydriatic imaging has lower resolution and lower
image quality leading to poorer detection of DR [17, 49].
However, digital imaging has lower technical failure rates
than imaging using colour slides [50]. The hand-held
non-mydriatic camera used in this study required a
minimum of 3.5 mm pupil diameter and average pupil
diameter in this study population was 2.01mm at pres-
entation. When pupils were dilated, proportion of
ungradable images was reduced from 43.4 to 12.8%.
Even at the reference test 37 eyes were ungradable due
to lens opacity. The improvement of image quality in
people with dark irises by pupil dilatation has been dem-
onstrated in a previous study [17]. The referral of
ungradable images to an ophthalmologist’s clinic is in
the best interest of patient safety. Scanlon, P. et al.
showed that in the > 80 years age group the technical
failure rates reduced from 41.6 to 16.9% following my-
driasis [18]. This study concluded that the odds of hav-
ing one eye ungradable, increased by 2.6% (95% CI 1.6–
3.7%) for each extra year of life since diagnosis of DM
and major cause of ungradable images was having a cen-
tral cataract (57%) [18]. Therefore, a non-mydriatic strat-
egy with dilatation of pupil for ungradable images only
would be more appropriate for this context. Another
reason for low DTA in non-mydriatic imaging could be
low resolution, which may have led to poor visibility of
delicate signs such as microaneurysms, as suggested in
the study by Henriccson et al. (2000) [43].
Limitations
We excluded PwDM with previous eye screening or
treatment, which reduced the proportion of people with
DR, which may have introduced spectrum bias. How-
ever, the resulting sample included a wide range of path-
ologies, albeit with fewer people with more advanced
disease. When considering any DR as referable level,
there were 301 DR positive and 1041 DR negative eyes
in the analysis. There were only 69 DR positive eyes
when considering moderate NPDR and above as the re-
ferable level. However, PwDM who already visited the
eye clinic would not usually participate in a screening
programme, therefore the sample examined in this study
reflects the PwDM who would be eligible for DRS. An-
other limitation was high proportion of ungradable im-
ages from non-mydriatic imaging compared to other
studies. However, the populations in LMICs have a
higher prevalence of untreated cataracts, which would
prevent adequate retinal view and would require referral.
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In a potential DRSP, these participants will be referred
to the next level of eye care and the patient would bene-
fit from the imaging even if the DR status remains
unknown.
The most common gold standard for a reference test
would be the ETDRS 7-field image grading by an expert
grader. However, it was not possible in this setting for a
large sample due to resource and time limitations. In
addition, any misclassifications in the clinical reference
test could have been mitigated, with a second reference
grader. In order to have a higher precision of the DTA,
the sample size should be adjusted according to the re-
ported low prevalence of higher grades of DR such as se-
vere NPDR and PDR.
Our proposed DRS modality of using a hand-held
non-mydriatic retinal camera at a medical clinic may be
more appropriate for a resource poor LMIC setting, with
the rising prevalence of DM. However, the caution is qual-
ity of the images. Our findings may not applicable to a HIC
setting where there are more resources and avenues for de-
velopment of a population-based DRS program using
table-top digital imaging systems. On the other hand, this
modality can be piggy back in a population-based program
in any setting, to improve the access.
Conclusion
In this study we demonstrated that the diagnostic test ac-
curacy of the physician graders was closer to the standard
practice of national level screening programs in other set-
tings. We conclude that 2-field retinal imaging using a
hand-held digital camera at a medical clinic, by physician
graders, with dilatation of pupil of those who have ungrad-
able images, provides a valid modality to identify referable
level of diabetic retinopathy. This strategy is an accurate
screening method of detection of a referable level in a
health care facility-based people with diabetes who are at
risk of developing sight threatening diabetic retinopathy.
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